Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

BACKGROUND: Pragmatic use of the anti-fibrotic medications pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF) in the United States (US) has not been studied and may be different from international settings due to structural differences between health care systems. This study examined...

全面介紹

Na minha lista:
書目詳細資料
發表在:Respir Res
Main Authors: Holtze, Colin H., Freiheit, Elizabeth A., Limb, Susan L., Stauffer, John L., Raimundo, Karina, Pan, Wayne T., Flaherty, Kevin R., Kim, Hyun J.
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011239/
https://ncbi.nlm.nih.gov/pubmed/32041621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-1315-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍